REQUEST A DEMO
Total
USD $0.00
Search more companies

Biopharmacotech Sp. z o.o. sp. k. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Biopharmacotech Sp. z o.o. sp. k. Profile Updated: August 16, 2021
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Polish Download a sample report

Biopharmacotech Sp. z o.o. sp. k. is based in Poland. The head office is in Czestochowa. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. Biopharmacotech Sp. z o.o. sp. k. was incorporated on August 13, 2010. There are currently 23 (2020) people employed by Biopharmacotech Sp. z o.o. sp. k.. In its most recent financial highlights, the company reported a net sales revenue increase of 12.99% in 2020. Its’ total assets recorded a negative growth of 11.27%. In 2020, Biopharmacotech Sp. z o.o. sp. k.’s net profit margin increased by 1.74%.

Headquarters
Ul. Gruszowa 47
Czestochowa; Slaskie; Postal Code: 42-215

Contact Details: Purchase the Biopharmacotech Sp. z o.o. sp. k. report to view the information.

Website: http://biopharmacotech1.home.pl/

Basic Information
Total Employees:
Purchase the Biopharmacotech Sp. z o.o. sp. k. report to view the information.
Outstanding Shares:
Purchase the Biopharmacotech Sp. z o.o. sp. k. report to view the information.
Financial Auditors:
Purchase the Biopharmacotech Sp. z o.o. sp. k. report to view the information.
Incorporation Date:
August 13, 2010
Key Executives
Company Performance
Financial values in the chart are available after Biopharmacotech Sp. z o.o. sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
12.99%
Total operating revenue
13.12%
Operating profit (EBIT)
32.8%
EBITDA
25.97%
Net Profit (Loss) for the Period
45.44%
Total assets
-11.27%
Total equity
47.23%
Operating Profit Margin (ROS)
1.13%
Net Profit Margin
1.74%
Return on Equity (ROE)
-0.65%
Debt to Equity Ratio
21.47%
Quick Ratio
0.01%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?